688265 南模生物
已收盘 01-13 15:00:01
资讯
新帖
简况
1月12日南模生物现1笔溢价13.95%的大宗交易 合计成交1514.59万元
证券之星 · 01-12 17:50
1月12日南模生物现1笔溢价13.95%的大宗交易 合计成交1514.59万元
南模生物（688265）披露拟参投心聚策源创业基金，1月9日股价上涨4.39%
证券之星 · 01-09
南模生物（688265）披露拟参投心聚策源创业基金，1月9日股价上涨4.39%
每周股票复盘：南模生物（688265）拟投6500万参与策源一期基金
证券之星 · 01-02
每周股票复盘：南模生物（688265）拟投6500万参与策源一期基金
南模生物（688265）披露参与投资策源一期基金暨关联交易，12月30日股价下跌0.29%
证券之星 · 2025-12-30
南模生物（688265）披露参与投资策源一期基金暨关联交易，12月30日股价下跌0.29%
南模生物最新公告：拟6500万元参投策源一期基金投资人工智能、航空航天、量子科技、机器人等领域
证券之星 · 2025-12-30
南模生物最新公告：拟6500万元参投策源一期基金投资人工智能、航空航天、量子科技、机器人等领域
南模生物（688265）披露回购股份减持时间届满未减持股份的结果公告，12月18日股价上涨3.31%
证券之星 · 2025-12-18
南模生物（688265）披露回购股份减持时间届满未减持股份的结果公告，12月18日股价上涨3.31%
南模生物（688265）披露回购股份集中竞价减持股份进展公告，12月02日股价下跌2.34%
证券之星 · 2025-12-02
南模生物（688265）披露回购股份集中竞价减持股份进展公告，12月02日股价下跌2.34%
专职研发人员降至5人，百奥赛图估值靠什么支撑？
投资时报 · 2025-12-01
专职研发人员降至5人，百奥赛图估值靠什么支撑？
每周股票复盘：南模生物（688265）2025年营收目标较2023年增不低于10%
证券之星 · 2025-11-16
每周股票复盘：南模生物（688265）2025年营收目标较2023年增不低于10%
每周股票复盘：南模生物（688265）将举办三季报业绩说明会
证券之星 · 2025-11-09
每周股票复盘：南模生物（688265）将举办三季报业绩说明会
每周股票复盘：南模生物（688265）Q3净利增242.07%
证券之星 · 2025-11-02
每周股票复盘：南模生物（688265）Q3净利增242.07%
南模生物（688265）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 2025-10-31
南模生物（688265）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
图解南模生物三季报：第三季度单季净利润同比增长242.07%
证券之星 · 2025-10-29
图解南模生物三季报：第三季度单季净利润同比增长242.07%
南模生物跌4.06% 2021年上市即巅峰募16.5亿元
中国经济网 · 2025-10-27
南模生物跌4.06% 2021年上市即巅峰募16.5亿元
每周股票复盘：南模生物（688265）尚未减持已回购股份
证券之星 · 2025-10-12
每周股票复盘：南模生物（688265）尚未减持已回购股份
南模生物（688265）发布选举董事长、董事会专门委员会委员、聘任高级管理人员、证券事务代表及指定董事长代行董事会秘书职责的公告，9月29日股价上涨0.99%
证券之星 · 2025-09-29
南模生物（688265）发布选举董事长、董事会专门委员会委员、聘任高级管理人员、证券事务代表及指定董事长代行董事会秘书职责的公告，9月29日股价上涨0.99%
每周股票复盘：南模生物（688265）推全人源抗体小鼠品系
证券之星 · 2025-09-21
每周股票复盘：南模生物（688265）推全人源抗体小鼠品系
南模生物（688265）披露拟调整董事会席位并取消监事会，9月17日股价上涨1.89%
证券之星 · 2025-09-17
南模生物（688265）披露拟调整董事会席位并取消监事会，9月17日股价上涨1.89%
南模生物跌4.09% 2021年上市即巅峰募16.5亿元
中金财经 · 2025-09-10
南模生物跌4.09% 2021年上市即巅峰募16.5亿元
每周股票复盘：南模生物（688265）Q2净利增409.77%
证券之星 · 2025-08-31
每周股票复盘：南模生物（688265）Q2净利增409.77%
加载更多
公司概况
公司名称：
上海南方模式生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2021-12-28
主营业务：
上海南方模式生物科技股份有限公司的主营业务是基因修饰动物模型的研发、生产、销售及相关技术服务。公司的主要产品是定制化模型、标准化模型、模型繁育、药效评价及表型分析、饲养服务、其他模式生物技术服务。
发行价格：
84.62
{"stockData":{"symbol":"688265","market":"SH","secType":"STK","nameCN":"南模生物","latestPrice":49.44,"timestamp":1768287601000,"preClose":47.3,"halted":0,"volume":3163595,"delay":0,"changeRate":0.0452,"floatShares":77963500,"shares":77963500,"eps":0.6216,"marketStatus":"已收盘","change":2.14,"latestTime":"01-13 15:00:01","open":47.4,"high":51.48,"low":47.4,"amount":157000000,"amplitude":0.0863,"askPrice":49.44,"askSize":97,"bidPrice":49.24,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.6216,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":47.3,"symbolType":"stock_kcb","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":52.03,"lowLimit":42.57,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":77963513,"isCdr":false,"pbRate":2.26,"roa":"--","peRate":79.53668,"roe":"1.58%","epsLYR":0.08,"committee":-0.721805,"marketValue":3855000000,"turnoverRate":0.0406,"status":0,"afterMarket":{"amount":0,"volume":0,"close":49.44,"buyVolume":0,"sellVolume":0,"time":1768289637558,"indexStatus":"已收盘 01-13 15:30:00","preClose":47.3},"floatMarketCap":3855000000},"requestUrl":"/m/hq/s/688265","defaultTab":"news","newsList":[{"id":"2602513675","title":"1月12日南模生物现1笔溢价13.95%的大宗交易 合计成交1514.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602513675","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602513675?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:50","pubTimestamp":1768211449,"startTime":"0","endTime":"0","summary":"近三个月该股共发生2笔大宗交易，合计成交3441.0手，溢价成交2笔。该股近期无解禁股上市。截至2026年1月12日收盘，南模生物报收于47.3元，上涨0.92%，换手率2.06%，成交量1.6万手，成交额7461.82万元。该股近半年内有股东持股变动，合计净增持289.05万股，股东增减持明细如下表：该股最近90天内无机构评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200025283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"gpt_icon":0},{"id":"2602337498","title":"南模生物（688265）披露拟参投心聚策源创业基金，1月9日股价上涨4.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602337498","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602337498?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:29","pubTimestamp":1767968953,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，南模生物报收于46.87元，较前一交易日上涨4.39%，最新总市值为36.54亿元。该股当日开盘44.51元，最高47.01元，最低44.11元，成交额达1.12亿元，换手率为3.14%。公司近日发布公告称，拟以自有资金6,500万元参与投资上海心聚策源一期创业投资合伙企业，出资比例约15.05%，成为其有限合伙人。本次投资构成关联交易，已获董事会审议通过，尚需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"gpt_icon":0},{"id":"2600394720","title":"每周股票复盘：南模生物（688265）拟投6500万参与策源一期基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2600394720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600394720?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:25","pubTimestamp":1767299110,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，南模生物报收于41.25元，较上周的41.74元下跌1.17%。本周关注点公司公告汇总：南模生物拟认缴6,500万元参与策源一期基金扩募，构成关联交易。上海南方模式生物科技股份有限公司公布2025年限制性股票激励计划预留授予激励对象名单，共计26名激励对象获授26.00万股限制性股票，占本激励计划授予总量的20.00%，占公司总股本的0.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"gpt_icon":0},{"id":"2595713833","title":"南模生物（688265）披露参与投资策源一期基金暨关联交易，12月30日股价下跌0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595713833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595713833?lang=zh_cn&edition=full","pubTime":"2025-12-30 22:37","pubTimestamp":1767105435,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘，南模生物报收于41.33元，较前一交易日下跌0.29%，最新总市值为32.22亿元。该股当日开盘41.65元，最高41.84元，最低41.05元，成交额达1538.94万元，换手率为0.48%。近日，南模生物发布关于参与投资策源一期基金暨关联交易的公告。公告显示，南模生物拟作为有限合伙人认缴6,500万元参与策源一期基金扩募，基金总认缴出资额将达4.32亿元，公司出资占比15.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000044497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"gpt_icon":0},{"id":"2595796305","title":"南模生物最新公告：拟6500万元参投策源一期基金投资人工智能、航空航天、量子科技、机器人等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2595796305","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595796305?lang=zh_cn&edition=full","pubTime":"2025-12-30 18:20","pubTimestamp":1767090008,"startTime":"0","endTime":"0","summary":"南模生物(688265.SH)公告称，公司拟作为有限合伙人认缴出资人民币6500万元参与上海心聚策源一期创业投资合伙企业（有限合伙）的扩募，扩募后基金规模为4.32亿元，公司出资比例为15.05%。该基金投资范围包括新材料、人工智能、航空航天、量子科技、机器人、高端装备、生物产业等战略性新兴产业的科技创新型项目和企业。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000031848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159227","688265","BK0216","161631"],"gpt_icon":0},{"id":"2592073719","title":"南模生物（688265）披露回购股份减持时间届满未减持股份的结果公告，12月18日股价上涨3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592073719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592073719?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:53","pubTimestamp":1766069596,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘，南模生物报收于41.5元，较前一交易日上涨3.31%，最新总市值为32.35亿元。近日，南模生物发布关于回购股份减持时间届满未减持股份的结果公告。2025年8月29日，公司披露减持计划，拟减持不超过779,635股，减持期间为2025年9月19日至12月18日。截至2025年12月18日，减持计划时间届满，公司未实施减持，当前持股数量仍为2,346,309股，持股比例3.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800039422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"gpt_icon":0},{"id":"2588051601","title":"南模生物（688265）披露回购股份集中竞价减持股份进展公告，12月02日股价下跌2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588051601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588051601?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:39","pubTimestamp":1764686369,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，南模生物报收于40.83元，较前一交易日下跌2.34%，最新总市值为31.83亿元。公司近日发布《关于回购股份集中竞价减持股份进展公告》。2025年8月29日，公司披露减持计划，拟减持不超过779,635股，减持期间为2025年9月19日至11月30日。截至2025年11月30日，公司尚未减持已回购股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200040372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"gpt_icon":0},{"id":"2588983779","title":"专职研发人员降至5人，百奥赛图估值靠什么支撑？","url":"https://stock-news.laohu8.com/highlight/detail?id=2588983779","media":"投资时报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588983779?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:18","pubTimestamp":1764602280,"startTime":"0","endTime":"0","summary":"创新药研发投入较大叠加三年净利润累计亏损近10亿元，百奥赛图资金压力加剧“基因编辑第一股”——百奥赛图（北京）医药科技股份有限公司（下称百奥赛图，2315.HK）距离实现“H+A”两地上市 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251201/c672879464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688046","688265","BK0216"],"gpt_icon":0},{"id":"2583654525","title":"每周股票复盘：南模生物（688265）2025年营收目标较2023年增不低于10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583654525","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583654525?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:38","pubTimestamp":1763239091,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，南模生物报收于44.32元，较上周的44.56元下跌0.54%。本周，南模生物11月12日盘中最高价报45.4元。本周关注点来自机构调研要点：2025年上半年海外业务收入占比约13.44%，公司将加大北美BD团队建设。来自机构调研要点：公司设定2025-2027年营收较2023年增长分别不低于10%、21%和33%。答：2025年上半年，海外业务收入占比约为13.44%。答：2025年前三季度，公司研发投入占营业收入比例约为20.72%。公司已构建超22,000种模型，覆盖常用小鼠模型。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265"],"gpt_icon":0},{"id":"2582418861","title":"每周股票复盘：南模生物（688265）将举办三季报业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2582418861","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582418861?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:11","pubTimestamp":1762632672,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，南模生物报收于44.56元，较上周的50.6元下跌11.94%。本周，南模生物11月3日盘中最高价报51.0元。本周关注点公司公告汇总：南模生物将于2025年11月13日举行三季报业绩说明会。说明会后可通过上证路演中心查看召开情况及主要内容。截至2025年10月31日，公司尚未减持已回购股份。公司将在每月前3个交易日内披露出售进展情况。本次减持不会导致公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"gpt_icon":0},{"id":"2580474244","title":"每周股票复盘：南模生物（688265）Q3净利增242.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580474244","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580474244?lang=zh_cn&edition=full","pubTime":"2025-11-02 06:05","pubTimestamp":1762034725,"startTime":"0","endTime":"0","summary":"本周关注点来自业绩披露要点：南模生物2025年第三季度归母净利润同比增长242.07%。股本股东变化股东户数变动截至2025年9月30日，南模生物股东户数为6687户，较6月30日增加165户，增幅2.53%。2025年前三季度营业收入302,700,815.36元，同比增长14.29%；归属于上市公司股东的净利润26,764,905.11元，同比增长276.14%。第三季度单季度营业收入106,937,671.62元，同比增长21.52%；归母净利润8,597,530.11元，同比增长242.07%。研发投入合计62,717,010.22元，占营业收入比例20.72%，同比下降0.89个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"gpt_icon":0},{"id":"2579109258","title":"南模生物（688265）2025年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579109258","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579109258?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:27","pubTimestamp":1761863271,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期南模生物发布2025年三季报。截至本报告期末，公司营业总收入3.03亿元，同比上升14.29%，归母净利润2676.49万元，同比上升276.14%。按单季度数据看，第三季度营业总收入1.07亿元，同比上升21.52%，第三季度归母净利润859.75万元，同比上升242.07%。本报告期南模生物盈利能力上升，毛利率同比增幅21.17%，净利率同比增幅254.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100008207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265"],"gpt_icon":0},{"id":"2579033459","title":"图解南模生物三季报：第三季度单季净利润同比增长242.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579033459","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579033459?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:06","pubTimestamp":1761739610,"startTime":"0","endTime":"0","summary":"证券之星消息，南模生物2025年三季报显示，前三季度公司主营收入3.03亿元，同比上升14.29%；归母净利润2676.49万元，同比上升276.14%；扣非净利润1027.79万元，同比上升131.85%；其中2025年第三季度，公司单季度主营收入1.07亿元，同比上升21.52%；单季度归母净利润859.75万元，同比上升242.07%；单季度扣非净利润436.36万元，同比上升137.44%；负债率10.38%，投资收益147.57万元，财务费用145.38万元，毛利率52.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900041066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265"],"gpt_icon":0},{"id":"2578613646","title":"南模生物跌4.06% 2021年上市即巅峰募16.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578613646","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578613646?lang=zh_cn&edition=full","pubTime":"2025-10-27 16:36","pubTimestamp":1761554160,"startTime":"0","endTime":"0","summary":"中国经济网北京10月27日讯南模生物(688265.SH)今日收报47.49元，跌幅4.06%。该股目前处于破发状态。南模生物于2021年12月28日在上交所科创板上市，发行股票数量为1949.09万股，发行价格为84 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20251027/c672027024.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251027/c672027024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0216","688265"],"gpt_icon":0},{"id":"2574457412","title":"每周股票复盘：南模生物（688265）尚未减持已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2574457412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574457412?lang=zh_cn&edition=full","pubTime":"2025-10-12 01:58","pubTimestamp":1760205490,"startTime":"0","endTime":"0","summary":"公司公告汇总关于回购股份集中竞价减持股份进展公告上海南方模式生物科技股份有限公司于2024年2月23日至5月22日通过集中竞价交易方式累计回购股份788,912股，占公司总股本的1.0119%，拟用于维护公司价值及股东权益，并在披露回购结果公告日后12个月后出售，3年内完成转让。2025年8月29日，公司披露减持计划，拟通过集中竞价方式减持不超过779,635股，减持期间为公告披露之日起15个交易日后的3个月内。截至2025年9月30日，公司尚未减持已回购股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"gpt_icon":0},{"id":"2571733785","title":"南模生物（688265）发布选举董事长、董事会专门委员会委员、聘任高级管理人员、证券事务代表及指定董事长代行董事会秘书职责的公告，9月29日股价上涨0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571733785","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571733785?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:32","pubTimestamp":1759156343,"startTime":"0","endTime":"0","summary":"近日，南模生物发布公告称，公司于2025年9月26日召开第四届董事会第一次会议，选举费俭先生为董事长，并选举产生董事会各专门委员会委员。审计委员会由尹向东任主任，提名委员会由郑依彤任主任，薪酬与考核委员会由于谦龙任主任，战略委员会由费俭任主任。原董事会秘书刘雯不再任职，董事长费俭将代行董事会秘书职责，直至公司聘任新的董事会秘书。上述人员任期均至第四届董事会任期届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900035542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265","161027"],"gpt_icon":0},{"id":"2569245986","title":"每周股票复盘：南模生物（688265）推全人源抗体小鼠品系","url":"https://stock-news.laohu8.com/highlight/detail?id=2569245986","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569245986?lang=zh_cn&edition=full","pubTime":"2025-09-21 03:09","pubTimestamp":1758395353,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，南模生物报收于54.15元，较上周的58.08元下跌6.77%。本周，南模生物9月17日盘中最高价报60.98元。2025年上半年推出具自主知识产权的人源化抗体转基因小鼠SmocMab品系，携带人源抗体重链和轻链可变区基因簇，同时破坏鼠源相应基因表达，可高效产生全人源抗体。公司已完成SmocMab品系对多种抗原的免疫反应检测，结果符合预期，并已建立全流程全人源抗体发现技术体系。在全人源单重链抗体、共轻链抗体模型研发方面亦取得显著进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"gpt_icon":0},{"id":"2568758464","title":"南模生物（688265）披露拟调整董事会席位并取消监事会，9月17日股价上涨1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568758464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568758464?lang=zh_cn&edition=full","pubTime":"2025-09-17 17:35","pubTimestamp":1758101700,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，南模生物报收于59.7元，较前一交易日上涨1.89%，最新总市值为46.54亿元。该股当日开盘58.81元，最高60.98元，最低56.7元，成交额达1.09亿元，换手率为2.39%。同日，南模生物发布公告称，公司拟召开2025年第二次临时股东大会，审议多项公司治理相关议案。公告显示，公司将调整董事会席位至11人，并取消监事会，同时修订《公司章程》及相关治理制度。会议将于近日召开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700030556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"gpt_icon":0},{"id":"2566967418","title":"南模生物跌4.09% 2021年上市即巅峰募16.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566967418","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566967418?lang=zh_cn&edition=full","pubTime":"2025-09-10 17:26","pubTimestamp":1757496363,"startTime":"0","endTime":"0","summary":"中国经济网北京9月10日讯 南模生物 今日股价下跌，截至收盘，该股报54.64元，跌幅4.09%。该股目前处于破发状态。 南模生物于2021年12月28日在上交所科创板上市，发行股票数量为1949.09万股，发行价格为84.62元/股，保荐人为海通证券股份有限公司，保荐代表人为张子慧、陈亚聪。 南模生物上市首日盘中最高价报82.00元，为该股上市以来最高价。 南模生物首次公开发行股票的发行费用总额为1.81亿元，其中，保荐及承销费用1.58亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20250910/31631231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","688265"],"gpt_icon":0},{"id":"2563835321","title":"每周股票复盘：南模生物（688265）Q2净利增409.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563835321","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563835321?lang=zh_cn&edition=full","pubTime":"2025-08-31 09:03","pubTimestamp":1756602191,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，南模生物报收于62.09元，较上周的59.55元上涨4.27%。本周关注点来自业绩披露要点：2025年第二季度归母净利润同比上升409.77%。股本股东变化截至2025年6月30日，南模生物股东户数为6522户，较3月31日增加270户，增幅4.32%。2025年第二季度单季度营业收入1.07亿元，同比上升14.32%；单季度归母净利润1913.42万元，同比上升409.77%；单季度扣非净利润1325.54万元，同比上升731.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100002766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768319125057,"stockEarnings":[{"period":"1week","weight":0.0765},{"period":"1month","weight":0.1605},{"period":"3month","weight":0.0185},{"period":"6month","weight":0.3612},{"period":"1year","weight":1.1807},{"period":"ytd","weight":0.1534}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":0.0709},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1888},{"period":"1year","weight":0.3146},{"period":"ytd","weight":0.0495}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海南方模式生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6687人(较上一季度增加2.53%)","perCapita":"11658股","listingDate":"2021-12-28","address":"上海市浦东新区琥珀路63弄1号6层","registeredCapital":"7796万元","survey":" 上海南方模式生物科技股份有限公司的主营业务是基因修饰动物模型的研发、生产、销售及相关技术服务。公司的主要产品是定制化模型、标准化模型、模型繁育、药效评价及表型分析、饲养服务、其他模式生物技术服务。","listedPrice":84.62},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南模生物(688265)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南模生物(688265)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南模生物,688265,南模生物股票,南模生物股票老虎,南模生物股票老虎国际,南模生物行情,南模生物股票行情,南模生物股价,南模生物股市,南模生物股票价格,南模生物股票交易,南模生物股票购买,南模生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南模生物(688265)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南模生物(688265)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}